e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?
Cerri S., du Bois R.M., Spagnolo P.
Source:
Eur Respir J 2011; 37: 489-491
Journal Issue:
March
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cerri S., du Bois R.M., Spagnolo P.. Genetic commonality between inflammatory bowel disease and sarcoidosis: the beginning of the end or the end of the beginning?. Eur Respir J 2011; 37: 489-491
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
Managing end stage disease in ILDs
Source: ERS Course 2016
Year: 2016
Managing end stage disease in ILDs
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018
Bronchial inflammation, respiratory symptoms and lung function in patients who finished treatment for pulmonary tuberculosis: is it the beginning of a new disease?
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019
Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Early and late onset asthma: are they the same?
Source: International Congress 2019 – Asthma and allergies worldwide
Year: 2019
Tuberculosis: considerations on the period between disease beginning and diagnosis moment
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001
Disease stratification in idiopathic pulmonary fibrosis: the dawn of a new era?
Source: Eur Respir J 2014; 43: 1233-1236
Year: 2014
Do airway diseases start in the early life?
Source: ERS Course 2019 - Masterclass in airways disease 2019
Year: 2019
Presentation by an expert: IL33 and onset of chronic lung disease
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013
Targeting interleukin-13 in idiopathic pulmonary fibrosis: from promising path to dead end
Source: Eur Respir J, 52 (6) 1802111; 10.1183/13993003.02111-2018
Year: 2018
Does the HLA-DRB1-genotype influence the course of disease in Danish sarcoidosis patients?
Source: Annual Congress 2013 –Sarcoidosis
Year: 2013
Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters
Source: Eur Respir J 2004; 24: Suppl. 48, 667s
Year: 2004
Monitoring disease progression in COPD patients: one step beyond!
Source: Eur Respir J 2014; 43: 665-667
Year: 2014
Radiological diagnosis of interstitial lung disease: is it all about pattern recognition?
Source: Eur Respir J, 52 (2) 1801321; 10.1183/13993003.01321-2018
Year: 2018
Pulmonary involvement in inflammatory bowel disease
Source: Annual Congress 2010 - Pulmonary involvement in disorders of the gastrointestinal system
Year: 2010
Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence?
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Targeted treatment of idiopathic pulmonary fibrosis: one step at a time
Source: Eur Respir J 2016; 47:1321-1323
Year: 2016
The light at the end of the tunnel: is COPD prevalence changing?
Source: Eur Respir J 2010; 36: 718-719
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept